Second-Hand Smoke is an Adjuvant for T Helper-2 Responses in a Murine Model of Allergy

Journal of Immunology

Volumn 159, Issue 12, 1997, Pages 6169-6175

  Seymour, Brian W P ^a,b   Pinkerton, Kent E ^c   Friebertshauser, Kathleen E ^b   Coffman, Robert L ^a   Gershwin, Laurel J ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOLOGICAL ADJUVANT; OVALBUMIN;

AEROSOL; ANIMAL; ANTIBODY PRODUCTION; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; CYTOLOGY; DISEASE MODEL; ENVIRONMENTAL EXPOSURE; FEMALE; IMMUNOLOGY; INDOOR AIR POLLUTION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG; LUNG LAVAGE; MALE; MOUSE; RESPIRATORY TRACT ALLERGY; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; AEROSOLS; ANIMALS; ANTIBODY FORMATION; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; ENVIRONMENTAL EXPOSURE; FEMALE; INJECTIONS, INTRAPERITONEAL; LUNG; MALE; MICE; MICE, INBRED BALB C; OVALBUMIN; RESPIRATORY HYPERSENSITIVITY; TH2 CELLS; TOBACCO SMOKE POLLUTION;

EID: 0031573519     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.159.12.6169     Document Type: Article

References (37)

1. Sopori, M. L., S. M. Savage, R. F. Christner, Y. M. Geng, and L. A. Donaldson, eds. 1993. Cigarette smoke and the immune response: mechanism of nicotine induced immunosuppression. In Alcohol, Drugs of Abuse and Immunomodulanon, Vol. 86. R. R. Watson, ed. Pergamon Press, Oxford, p. 663.
2. Stone, R. 1992. Bad news on second-hand smoke. Science 257:607.
3. Witschi, H, J. P. Joad, and K. E. Pinkerton. 1997. The toxicology of environmental tobacco smoke. Annu. Rev. Pharmacol. Toxicol. 37:29.
4. Ronchetti, R., E. Bonci, R. Cutrera, C. G. De, L. Indinnimeo, F. Midulla, G. Tancredi, and F. D. Martinez. 1992. Enhanced allergic sensitisation related to parental smoking. Arch. Dis. Child. 67:496.
5. El-Nawawy, A., A. T. Soliman, O. El-Azzouni, E. Amer, S. Demian, and M. El-Sayed. 1996. Effect of passive smoking on frequency of respiratory illnesses and serum immunoglobulin-E (IgE) and interleukin-4 (IL-4) concentrations in exposed children. J. Trop. Pediatr. 42:166.
6. Teague, S. V., K. E. Pinkerton, M. Goldsmith, A. Gebremichael, S. Chang, R. A. Jenkins, and J. H. Moneyhun. 1994. A sidestream cigarette smoke generation and exposure system for environmental tobacco smoke studies. Inhalation Toxicol. 6:79.
7. Medin, N. I., J. W. Osebold, and Y. C. Zee. 1976. A procedure for pulmonary lavage in mice. Am. J. Vet. Res. 37:237.
8. Colley, D. G. 1972. Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp. Parasitol. 32:520.
9. Coffman, R. L., and J. Carty. 1986. A T cell activity that enhances polyclonal IgE production and its inhibition by interferon-γ. J. Immunol. 136:949.
10. Abrams, J. 1995. Immunoenzymetric assay of mouse and human cytokines using NIP-labeled anti-cytokine antibodies. In Current Protocols in Immunology, Vol. 6. R. Roico, ed. John Wiley & Sons, Inc., New York, p. 6.20.1.
11. Leher, S. B., M. R. Wilson, R. M. Karr, and J. E. Salvaggio. 1980. IgE antibody response of smokers, nonsmokers, and "smoke-sensitive" persons to tobacco leaf and smoke antigens. Am. Rev. Respir. Dis. 121:168.
12. Revoltella, R., and Z. Ovary. 1969. Reaginic antibody production in different mouse strains. Immunology 17:45.
13. Hazenbos, W. L. W., J. E. Gessner, F. M. A. Hofhuis, H. Kuipers, D. Meyer, I. A. F. M. Heijnen, R. E. Schmidt, M. Sandor, P. J. A. Capel, M. Daeron, J. G. J. van de Winkel, and J. S. Verbeek. 1996. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5:181.
14. Janson, C., and M. Herala. 1992. Blood eosinophil count as risk factor for relapse in acute asthma. Respir. Med. 86:101.
15. Holt, P. G., and D. Keast. 1977. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol. Rev. 41:205.
16. Holt, P. G. 1987. Immune and inflammatory function in cigarette smokers. Thorax 42:241.
17. Thepen, T., R. N. Van, and G. Kraal. 1989. Alveolar macrophage elimination in vivo is associated with an increase in pulmonary immune response in mice. J. Exp. Med. 170:499.
18. Shephard, R. J. 1992. Respiratory irritation from environmental tobacco smoke. Arch. Environ. Health 47:123.
19. Stedman, R. L. 1968. The chemical composition of tobacco and tobacco smoke. Chem. Rev. 68:153.
20. Savage, S. M., L. A. Donaldson, S. Cherian, R. Chilukuri, V. A. White, and M. L. Sopori. 1991. Effects of cigarette smoke on the immune response. II. Chronic exposure to cigarette smoke inhibits surface immunoglobulin-mediated responses in B cells. Toxicol. Appl. Pharmacol. 111:523.
21. Geng, Y., S. M. Savage, L. J. Johnson, J. Seagrave, and M. L. Sopori. 1995. Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol. Appl. Pharmacol 135:268.
22. Geng, Y., S. M. Savage, S. Razani-Boroujerdi, and M. L. Sopori. 1996. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J. Immunol. 156:2384.
23. Rennick, D. M., S. L. Thompson, R. L. Coffman, B. W. P. Seymour, J. D. Jackson, and S. Hudak. 1990. In vivo administration of antibody to interleukin-5 inhibits increased generation of eosinophils and their progenitors in bone marrow of parasitized mice. Blood 76:312.
24. Lopez, A. F., C. J. Sanderson, J. R. Gamble, H. D. Campbell, I. G. Young, and M. A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219.
25. Coffman, R. L., B. W. P. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245:308.
26. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J. Exp. Med. 183:195.
27. Durham, S. R., S. Ying, V. A. Varney, M. R. Jacobsen, R. M. Sudderick, I. S. Mackay, A. B. Kay, and Q. A. Hamid. 1992. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148:2390.
28. Schleimer, R. P., S. A. Sterbinsky, J. Kaiser, C. A. Bickel, D. A. Klunk, K. Tomioka, W. Newman, F. W. Luscinskas, M. J. Gimbrone, B. W. McIntyre, and B. S. Bochner. 1992. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium: association with expression of VCAM-1. J. Immunol. 148:1086.
29. Brusselle, G., J. Kips, G. Joos, H. Bluethmann, and R. Pauwels. 1995. Allergen-induced airway inflammation and bronchial responsiveness in wild-type and interleukin-4-deficient mice. Am. J. Respir. Cell Mol. Biol. 12:254.
30. Powrie, F., S. Menon, and R. L. Coffman. 1993. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:3043.
31. Loetscher, P., M. Seitz, M. Baggiolini, and B. Moser. 1996. Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J. Exp. Med. 184:569.
32. van Halteren, A. G. S., M. J. F. van der Cammen, J. Biewenga, H. F. J. Savelkoul, and G. Kraal. 1997. IgE and mast cell responses on intestinal allergen exposure: a murine model to study the onset of food allergy. J. Allergy Clin. Immunol. 99:94.
33. Corbo, G. M., F. Forestiere, V. Dell'Orco, R. Pistelli, N. Agabiti, B. De Stefanis, B. Ciappi, and C. A. Perucci. 1993. Effects of environment on atopic status and respiratory disorders in children. J. Allergy Clin. Immunol. 92:616.
34. Diaz-Sanchez, D., A. Tsien, A. Casillas, A. R. Dotson, and A. Saxon. 1996. Enhanced nasal cytokine production in human beings after in vivo challenge with diesel exhaust particles. J. Allergy Clin. Immunol. 98:114.
35. Diaz-Sanchez, D., A. Tsien, J. Fleming, and A. Saxon. 1996. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J. Immunol. 158:2406.
36. Takenaka, H., K. Zhang, D. Diaz-Sanchez, A. Tsien, and A. Saxon. 1995. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J. Allergy Clin. Immunol. 95:102.
37. Scherer, G., C. Conze, A. R. Tricker, and F. Adlkofer. 1992. Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS). Clin. Investig. 70:352.